The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Research Report 2024
Synopsis
Global Circulating Tumor Cells (CTC) Liquid Biopsy market is projected to reach US$ 2642.3 million in 2029, increasing from US$ 1095 million in 2022, with the CAGR of 13.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Circulating Tumor Cells (CTC) Liquid Biopsy market research.
North America dominates global circulating tumor cells (CTC) liquid biopsy market. This is majorly due to the growing adoption of the liquid biopsy in the North American region for diagnosis of cancer. There are rapidly growing cases of cancer in US which has contributed in the dominance of North America in the global liquid biopsy market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Circulating Tumor Cells (CTC) Liquid Biopsy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
QIAGEN
Bio-Techne
Precision Medical
Aviva Systems Biological
Biocept
Fluxion Biosciences
Greiner Bio-One International GmbH
Ikonisys
Miltenyi Biotec
IVDiagnostics
BioFluidica
Canopus Medical
Biolidics
Creativ MicroTech
LungLife AI
Epic Sciences
Rarecells Diagnostics
ScreenCell
Menarini Silicon Biosystems
Segment by Type
Kits & Reagents
Blood Collection Tubes
Devices
Segment by Application
Research & Academic Institutes
Hospitals
Physician Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Circulating Tumor Cells (CTC) Liquid Biopsy report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global Circulating Tumor Cells (CTC) Liquid Biopsy market is projected to reach US$ 2642.3 million in 2029, increasing from US$ 1095 million in 2022, with the CAGR of 13.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Circulating Tumor Cells (CTC) Liquid Biopsy market research.
North America dominates global circulating tumor cells (CTC) liquid biopsy market. This is majorly due to the growing adoption of the liquid biopsy in the North American region for diagnosis of cancer. There are rapidly growing cases of cancer in US which has contributed in the dominance of North America in the global liquid biopsy market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Circulating Tumor Cells (CTC) Liquid Biopsy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
QIAGEN
Bio-Techne
Precision Medical
Aviva Systems Biological
Biocept
Fluxion Biosciences
Greiner Bio-One International GmbH
Ikonisys
Miltenyi Biotec
IVDiagnostics
BioFluidica
Canopus Medical
Biolidics
Creativ MicroTech
LungLife AI
Epic Sciences
Rarecells Diagnostics
ScreenCell
Menarini Silicon Biosystems
Segment by Type
Kits & Reagents
Blood Collection Tubes
Devices
Segment by Application
Research & Academic Institutes
Hospitals
Physician Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Circulating Tumor Cells (CTC) Liquid Biopsy report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Kits & Reagents
1.2.3 Blood Collection Tubes
1.2.4 Devices
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Research & Academic Institutes
1.3.3 Hospitals
1.3.4 Physician Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Perspective (2018-2029)
2.2 Circulating Tumor Cells (CTC) Liquid Biopsy Growth Trends by Region
2.2.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Circulating Tumor Cells (CTC) Liquid Biopsy Historic Market Size by Region (2018-2023)
2.2.3 Circulating Tumor Cells (CTC) Liquid Biopsy Forecasted Market Size by Region (2024-2029)
2.3 Circulating Tumor Cells (CTC) Liquid Biopsy Market Dynamics
2.3.1 Circulating Tumor Cells (CTC) Liquid Biopsy Industry Trends
2.3.2 Circulating Tumor Cells (CTC) Liquid Biopsy Market Drivers
2.3.3 Circulating Tumor Cells (CTC) Liquid Biopsy Market Challenges
2.3.4 Circulating Tumor Cells (CTC) Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTC) Liquid Biopsy Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTC) Liquid Biopsy Players by Revenue (2018-2023)
3.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Players (2018-2023)
3.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cells (CTC) Liquid Biopsy Revenue
3.4 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Liquid Biopsy Revenue in 2022
3.5 Circulating Tumor Cells (CTC) Liquid Biopsy Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cells (CTC) Liquid Biopsy Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cells (CTC) Liquid Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells (CTC) Liquid Biopsy Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Historic Market Size by Type (2018-2023)
4.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecasted Market Size by Type (2024-2029)
5 Circulating Tumor Cells (CTC) Liquid Biopsy Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Historic Market Size by Application (2018-2023)
5.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
6.2 North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2018-2023)
6.4 North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
7.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2018-2023)
7.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
8.2 Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2018-2023)
8.4 Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
9.2 Latin America Circulating Tumor Cells (CTC) Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2018-2023)
9.4 Latin America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2018-2029)
10.2 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2018-2023)
10.4 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Detail
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.1.4 QIAGEN Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.1.5 QIAGEN Recent Development
11.2 Bio-Techne
11.2.1 Bio-Techne Company Detail
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.2.4 Bio-Techne Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.2.5 Bio-Techne Recent Development
11.3 Precision Medical
11.3.1 Precision Medical Company Detail
11.3.2 Precision Medical Business Overview
11.3.3 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.3.4 Precision Medical Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.3.5 Precision Medical Recent Development
11.4 Aviva Systems Biological
11.4.1 Aviva Systems Biological Company Detail
11.4.2 Aviva Systems Biological Business Overview
11.4.3 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.4.4 Aviva Systems Biological Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.4.5 Aviva Systems Biological Recent Development
11.5 Biocept
11.5.1 Biocept Company Detail
11.5.2 Biocept Business Overview
11.5.3 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.5.4 Biocept Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.5.5 Biocept Recent Development
11.6 Fluxion Biosciences
11.6.1 Fluxion Biosciences Company Detail
11.6.2 Fluxion Biosciences Business Overview
11.6.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.6.4 Fluxion Biosciences Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.6.5 Fluxion Biosciences Recent Development
11.7 Greiner Bio-One International GmbH
11.7.1 Greiner Bio-One International GmbH Company Detail
11.7.2 Greiner Bio-One International GmbH Business Overview
11.7.3 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.7.4 Greiner Bio-One International GmbH Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.7.5 Greiner Bio-One International GmbH Recent Development
11.8 Ikonisys
11.8.1 Ikonisys Company Detail
11.8.2 Ikonisys Business Overview
11.8.3 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.8.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.8.5 Ikonisys Recent Development
11.9 Miltenyi Biotec
11.9.1 Miltenyi Biotec Company Detail
11.9.2 Miltenyi Biotec Business Overview
11.9.3 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.9.4 Miltenyi Biotec Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.9.5 Miltenyi Biotec Recent Development
11.10 IVDiagnostics
11.10.1 IVDiagnostics Company Detail
11.10.2 IVDiagnostics Business Overview
11.10.3 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.10.4 IVDiagnostics Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.10.5 IVDiagnostics Recent Development
11.11 BioFluidica
11.11.1 BioFluidica Company Detail
11.11.2 BioFluidica Business Overview
11.11.3 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.11.4 BioFluidica Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.11.5 BioFluidica Recent Development
11.12 Canopus Medical
11.12.1 Canopus Medical Company Detail
11.12.2 Canopus Medical Business Overview
11.12.3 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.12.4 Canopus Medical Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.12.5 Canopus Medical Recent Development
11.13 Biolidics
11.13.1 Biolidics Company Detail
11.13.2 Biolidics Business Overview
11.13.3 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.13.4 Biolidics Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.13.5 Biolidics Recent Development
11.14 Creativ MicroTech
11.14.1 Creativ MicroTech Company Detail
11.14.2 Creativ MicroTech Business Overview
11.14.3 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.14.4 Creativ MicroTech Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.14.5 Creativ MicroTech Recent Development
11.15 LungLife AI
11.15.1 LungLife AI Company Detail
11.15.2 LungLife AI Business Overview
11.15.3 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.15.4 LungLife AI Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.15.5 LungLife AI Recent Development
11.16 Epic Sciences
11.16.1 Epic Sciences Company Detail
11.16.2 Epic Sciences Business Overview
11.16.3 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.16.4 Epic Sciences Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.16.5 Epic Sciences Recent Development
11.17 Rarecells Diagnostics
11.17.1 Rarecells Diagnostics Company Detail
11.17.2 Rarecells Diagnostics Business Overview
11.17.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.17.4 Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.17.5 Rarecells Diagnostics Recent Development
11.18 ScreenCell
11.18.1 ScreenCell Company Detail
11.18.2 ScreenCell Business Overview
11.18.3 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.18.4 ScreenCell Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.18.5 ScreenCell Recent Development
11.19 Menarini Silicon Biosystems
11.19.1 Menarini Silicon Biosystems Company Detail
11.19.2 Menarini Silicon Biosystems Business Overview
11.19.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Introduction
11.19.4 Menarini Silicon Biosystems Revenue in Circulating Tumor Cells (CTC) Liquid Biopsy Business (2018-2023)
11.19.5 Menarini Silicon Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
